← All trials
NCT03335007
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2015
- Primary completion
- Jul 31, 2017
- Completion date
- Jul 31, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 70
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Cairo UniversityLead sponsor
- Cairo UniversityOverall official - principal investigator
- Cairo UniversityReponsible party - principal investigator
- Cairo UniversityStudy chair
- Cairo UniversityStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.